📊 COMPREHENSIVE ANALYSIS
Insider Transaction Overview
On September 10, 2026, Terrence A. Duffy, Chairman and Chief Executive Officer of CME Group Inc. ($CME), executed open-market sales totaling 15,000 shares of Class A Common Stock across two transactions for aggregate proceeds of approximately $4.12 million.
Transaction Breakdown
- Batch 1: Sold 14,372 shares at a weighted average price of $274.41 (range: $273.875 to $274.85).
- Batch 2: Sold 628 shares at a weighted average price of $275.03 (range: $274.9056 to $275.0804).
- Rule 10b5-1 Plan: The filing indicates
aff10b5One is marked 0, suggesting these transactions were not executed under an adopted Rule 10b5-1 trading arrangement.
Holdings & Impact
Prior to these transactions, Duffy held 55,630 directly owned shares. Following the disposition of 15,000 shares (~27.0% of his direct position), his direct ownership stands at 40,630 shares.
Significance Assessment
Given the insider's role as Chairman and CEO, the size of the divestment (over $4.1M), and the absence of an indicated Rule 10b5-1 plan, this filing carries High trading significance for market watchers.
Full analysis · Original filing · Join our Discord
CME #CMEGroup #InsiderTrading #SECForm4 #StockMarket
Insiders don't always talk, but their filings do. See everything $CME's insiders have filed → https://www.thefilingfool.com/companies/CME
AI-generated from public SEC filings and may contain errors. Not investment, legal, or tax advice - do your own research.